Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (172)

Clear all filters
Clear all filters

Vodobatinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Leukemia)

Drug Class / Mechanism

BCR-ABL Tyrosine Kinase Inhibitor

Vorinostat

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Lymphoma)

Drug Class / Mechanism

HDAC Inhibitor

Ziftomenib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic

Drug Class / Mechanism

EZH2 / Menin Inhibitor

Moxetumomab Pasudotox

Targeted Therapy (Antibody)

Therapeutic Category

Targeted Therapy (Antibody)

Oncology Type

Hematologic (Leukemia)

Drug Class / Mechanism

Anti-CD22 Pseudomonas Exotoxin Immunotoxin

Tabelecleucel

Cellular Therapy

Therapeutic Category

Cellular Therapy

Oncology Type

Hematologic

Drug Class / Mechanism

Allogeneic EBV-Specific T-Cell Immunotherapy

Zevorcabtagene Autoleucel

Cellular Therapy (CAR-T)

Therapeutic Category

Cellular Therapy (CAR-T)

Oncology Type

Hematologic (Multiple Myeloma)

Drug Class / Mechanism

Autologous Anti-BCMA CAR-T Cell Therapy

Arlocabtagene Autoleucel

Cellular Therapy (CAR-T)

Therapeutic Category

Cellular Therapy (CAR-T)

Oncology Type

Hematologic (Multiple Myeloma)

Drug Class / Mechanism

Autologous Anti-GPRC5D CAR-T Cell Therapy

BGB-16673 (BTK Degrader)

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Hematologic

Drug Class / Mechanism

Targeted Protein Degrader

CFT7455 (Cereblon Degrader)

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Hematologic

Drug Class / Mechanism

Targeted Protein Degrader

Cibisatamab

Immunotherapy (Investigational)

Therapeutic Category

Immunotherapy (Investigational)

Oncology Type

Hematologic

Drug Class / Mechanism

CD47 (Macrophage Checkpoint) Inhibitor

Elenestinib

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Hematologic

Drug Class / Mechanism

Next-Generation KIT D816V Inhibitor

Emavusertib

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Hematologic

Drug Class / Mechanism

IRAK4 Kinase Inhibitor